126
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
INTERDISCIPLINARY RADIOBIOLOGY
CLINICAL BRACHYTHERAPY PHYSICS
RTT
YOUNG
MONDAY 2 MAY 2016
09:35 > Implementation of daily plan selection in rectum
Speaker: R. De Jong (The Netherlands)
SP-0423
Poster Viewing 9
RADIOBIOLOGY
08:45 - 10:00 | POSTER AREA
Chair: T. Brunner (Germany)
Chair: L. Marignol (Ireland)
> Cyclin D1 silencing radiosensitises prostate cancer cells by impairing
DNA-DSBs repair pathways.
F. Marampon (Italy), G. Gravina, C. Festuccia, A. Colapietro, E. Di Cesare,
E. Tombolini
PV-0424
> EEF2K promotes progression and radioresistance of esophageal squa-
mous cell carcinoma
H.C. Zhu (China), X. Yang, X.L. Ge, J.Y. Chen, H.M. Song, J. Liu, Z.L. Pei,
M.Q. Chen, X.C. Sun
PV-0425
> Targeting PI4K for radiosensitisation: a viable model of drug repositio-
ning
I.A. Kim (Republic of Korea), J. Kwon, Y. Park, D. Kim, J. Park
PV-0426
> Real-time tumour oxygenation changes following a single high dose
radiotherapy in mouse lung cancers
C. Song (Republic of Korea), B.J. Hong, S. Bok, C.J. Lee, Y.E. Kim,
S.R. Jeon, H.G. Wu, Y.S. Lee, G.J. Cheon, J.C. Paeng, G.O. Ahn, H.J. Kim
PV-0427
> Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX
assay in prostate cancer patients
C. De Colle (Italy), A. Menegakis, A.C. Mueller, A. Yaromina,
J. Hennenlotter, A. Stenzl, M. Scharpf, F. Fend, U. Ricardi, M. Baumann,
D. Zips
PV-0428
> A 3D in vitro cancer model and imaging platform to measure proton
radiation-induced cellular damage
T. Long (UK), M. Loizidou, G. Schettino, G. Royle, K. Ricketts
PV-0429
> Late radiation enteropathy: do tissue cytokines play a protective role?
A first-in-man study.
M. Reis Ferreira (UK), H.J.N. Andreyev, K. Mohammed,
S. Gowan, D.P. Dearnaley
PV-0430